You are here: Home » Current Affairs » Coronavirus » News
Business Standard

India will do best to facilitate Covid-19 vaccines: PM Modi to Trudeau

Prime Minister Narendra Modi on Wednesday assured his Canadian counterpart Justin Trudeau that India would do its best to facilitate supplies of Covid vaccines sought by Canada.

Topics
Coronavirus Vaccine | Narendra Modi | Justin Trudeau

Press Trust of India  |  New Delhi 

Serum Institute, Bharat Biotech ramp up Covid-19 vaccine export plan

Prime Minister on Wednesday assured his Canadian counterpart that India would do its best to facilitate supplies of COVID vaccines sought by Canada.

Trudeau, who made a telephone call to the prime minister, said that if the world managed to conquer COVID-19, it would be significantly because of India's tremendous pharmaceutical capacity and Modi's leadership in sharing this capacity with the world, according to a Prime Minister's Office (PMO) statement.

During the call, Prime Minister Trudeau informed Modi about Canada's requirements of COVID-19 vaccines from India.

Prime Minister Modi assured his Canadian counterpart that India would do its best to support Canada's vaccination efforts, just as it had done for many other countries already.

"Was happy to receive a call from my friend Assured him that India would do its best to facilitate supplies of COVID vaccines sought by Canada," Modi said in a tweet.

"We also agreed to continue collaborating on other important issues like Climate Change and the global economic recovery," he said.

The two leaders also reiterated the common perspective shared by India and Canada on many important geo-political issues. They agreed to continue the close collaboration between both countries in fighting global challenges like Climate Change and the economic impacts of the pandemic, the PMO said.

The leaders looked forward to meeting each other in various important international fora later this year, and continuing their discussions on all issues of mutual interest, it said.

India is one of the world's biggest drugmakers, and an increasing number of countries have already approached it for procuring coronavirus vaccines

Last week, external affairs ministry spokesperson Anurag Srivastava said India had sent 56 lakh doses of coronavirus vaccines under grants assistance to a number of countries while 100 lakh doses were sent under commercial supplies.

India has already rolled out a massive coronavirus vaccination drive under which two vaccines, Covishield and Covaxin, are being administered to frontline health workers across the country.

While Oxford-AstraZeneca's Covishield is being manufactured by the Serum Institute of India, and Covaxin is being produced by Bharat Biotech.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, February 11 2021. 01:20 IST
RECOMMENDED FOR YOU